These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21474973)

  • 1. Vascular pericyte density and angiogenesis associated with adenocarcinoma of the prostate.
    Killingsworth MC; Wu X
    Pathobiology; 2011; 78(1):24-34. PubMed ID: 21474973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent association of angiogenesis index with outcome in prostate cancer.
    Mehta R; Kyshtoobayeva A; Kurosaki T; Small EJ; Kim H; Stroup R; McLaren CE; Li KT; Fruehauf JP
    Clin Cancer Res; 2001 Jan; 7(1):81-8. PubMed ID: 11205922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
    Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
    Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computerized whole slide quantification shows increased microvascular density in pT2 prostate cancer as compared to normal prostate tissue.
    van Niekerk CG; van der Laak JA; Börger ME; Huisman HJ; Witjes JA; Barentsz JO; Hulsbergen-van de Kaa CA
    Prostate; 2009 Jan; 69(1):62-9. PubMed ID: 18780292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
    Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
    Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts.
    Welén K; Jennbacken K; Tesan T; Damber JE
    Prostate Cancer Prostatic Dis; 2009; 12(1):41-6. PubMed ID: 18521102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis and prostate cancer: identification of a molecular progression switch.
    Huss WJ; Hanrahan CF; Barrios RJ; Simons JW; Greenberg NM
    Cancer Res; 2001 Mar; 61(6):2736-43. PubMed ID: 11289156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma.
    Ozawa MG; Yao VJ; Chanthery YH; Troncoso P; Uemura A; Varner AS; Kasman IM; Pasqualini R; Arap W; McDonald DM
    Cancer; 2005 Nov; 104(10):2104-15. PubMed ID: 16208706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated angiogenesis in prostate cancer.
    Fregene TA; Khanuja PS; Noto AC; Gehani SK; Van Egmont EM; Luz DA; Pienta KJ
    Anticancer Res; 1993; 13(6B):2377-81. PubMed ID: 7510938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade.
    Li H; Gerald WL; Benezra R
    Cancer Res; 2004 Sep; 64(17):6137-43. PubMed ID: 15342397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
    Eberhard A; Kahlert S; Goede V; Hemmerlein B; Plate KH; Augustin HG
    Cancer Res; 2000 Mar; 60(5):1388-93. PubMed ID: 10728704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor expression and angiogenesis in human prostate carcinoma.
    Abdulkadir SA; Carvalhal GF; Kaleem Z; Kisiel W; Humphrey PA; Catalona WJ; Milbrandt J
    Hum Pathol; 2000 Apr; 31(4):443-7. PubMed ID: 10821491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis.
    Bono AV; Pannellini T; Liberatore M; Montironi R; Cunico SC; Cheng L; Sasso F; Musiani P; Iezzi M
    Anal Quant Cytol Histol; 2010 Jun; 32(3):136-45. PubMed ID: 20701066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
    Weidner N; Carroll PR; Flax J; Blumenfeld W; Folkman J
    Am J Pathol; 1993 Aug; 143(2):401-9. PubMed ID: 7688183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cellularity of tumor-encased native vessels in prostate carcinoma is a marker for tumor progression.
    Garcia FU; Taylor CA; Hou JS; Rukstalis DB; Stearns ME
    Mod Pathol; 2000 Jul; 13(7):717-22. PubMed ID: 10912929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The addition of AG-013736 to fractionated radiation improves tumor response without functionally normalizing the tumor vasculature.
    Fenton BM; Paoni SF
    Cancer Res; 2007 Oct; 67(20):9921-8. PubMed ID: 17942924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density.
    Wild R; Ramakrishnan S; Sedgewick J; Griffioen AW
    Microvasc Res; 2000 May; 59(3):368-76. PubMed ID: 10792968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer.
    Stefanou D; Batistatou A; Kamina S; Arkoumani E; Papachristou DJ; Agnantis NJ
    In Vivo; 2004; 18(2):155-60. PubMed ID: 15113042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: correlation with neovascularization.
    Sugamoto T; Tanji N; Sato K; Fujita H; Nishio S; Sakanaka M; Yokoyama M
    Anticancer Res; 2001; 21(1A):77-88. PubMed ID: 11299793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.